When HEKMs reached the tumour area, guided by binding to the EGFR-HER2 complex, the MMP-2 substrate was degraded (as confirmed through fluorescence energy transfer analysis), leading to the deformation of the nanorods into spheres, which aided deeper tumour penetration. Here, ERBB2 is linked to neoplasm.